{"id":16843,"date":"2021-03-12T10:35:19","date_gmt":"2021-03-12T09:35:19","guid":{"rendered":"https:\/\/idibell.cat\/?p=16843"},"modified":"2021-03-12T10:35:45","modified_gmt":"2021-03-12T09:35:45","slug":"la-unitat-dinvestigacio-clinica-en-assaigs-clinics-renova-la-seva-participacio-a-la-plataforma-de-suport-a-la-recerca-clinica-de-lisciii","status":"publish","type":"post","link":"https:\/\/idibell.cat\/2021\/03\/la-unitat-dinvestigacio-clinica-en-assaigs-clinics-renova-la-seva-participacio-a-la-plataforma-de-suport-a-la-recerca-clinica-de-lisciii\/","title":{"rendered":"La Unitat d\u2019Investigaci\u00f3 Cl\u00ednica en Assaigs Cl\u00ednics renova la seva participaci\u00f3 a la Plataforma de Suport a la Recerca Cl\u00ednica de l\u2019ISCIII"},"content":{"rendered":"<p>L\u2019ajut concedit en la darrera convocat\u00f2ria competitiva de Plataformes de Suport a la Recerca Cl\u00ednica de l\u2019Institut de Salut Carlos III (<a href=\"https:\/\/www.scren.es\/\">ISCIII<\/a>) gaireb\u00e9 triplica el concedit a la convocat\u00f2ria de l\u2019any 2017, essent <strong>una de les cinc unitats m\u00e9s ben dotades de les 34<\/strong> que conformen la nova Plataforma de l\u2019ISCIII a tot el territori de l\u2019estat espanyol.<\/p>\n<p>La Unitat d\u2019Investigaci\u00f3 Cl\u00ednica en Assaigs Cl\u00ednics (<a href=\"https:\/\/idibell.cat\/serveis\/serveis-cientificotecnics\/uicec\/\">UICEC<\/a>), liderada per la Dra Pilar Hereu, \u00e9s una Plataforma de l\u2019IDIBELL amb depend\u00e8ncia funcional del servei de Farmacologia Cl\u00ednica de l\u2019Hospital Universitari de Bellvitge (<a href=\"https:\/\/bellvitgehospital.cat\/es\/inicio\">HUB<\/a>) i integrada en el Departament de Recerca Cl\u00ednica de l\u2019IDIBELL. D\u00f3na servei als investigadors en l\u2019exercici de les seves funcions i responsabilitats <strong>com a promotors<\/strong> <strong>d\u2019estudis de recerca cl\u00ednica<\/strong> i en compliment de la legislaci\u00f3 vigent i les normes de bona pr\u00e0ctica cl\u00ednica.<\/p>\n<p>L\u2019activitat de la UICEC de l\u2019IDIBELL ha tingut un creixement sostingut en el per\u00edode 2017-2020, passant de 26 projectes actius al 2017 a els 45 estudis de recerca cl\u00ednica el 2020, repartits en algunes de les\u00a0 tasques que formen part de la seva cartera de serveis: la monitoritzaci\u00f3 dels estudis de recerca cl\u00ednica, la gesti\u00f3 de projectes, la tramitaci\u00f3 i gesti\u00f3 administrativa, i la farmacovigil\u00e0ncia dels assaigs cl\u00ednics.<\/p>\n<p>La distribuci\u00f3 d\u2019aquests 45 projectes ha sigut: 37 estudis al HUB, 3 a l\u2019ICO, 2 a l\u2019IDIBELL i 3 assaigs cl\u00ednics d\u2019investigadors externs. A m\u00e9s, durant l\u2019any 2020 la UICEC tamb\u00e9 ha donat suport a la posada en marxa de 6 assaigs cl\u00ednics que avaluen estrat\u00e8gies de tractament en la infecci\u00f3 pel <strong>Sars-Cov-2.<\/strong><\/p>\n<p>Com a Unitat de la Plataforma de Suport a la recerca Cl\u00ednica del ISCIII, forma part de la xarxa europea <strong>European Clinical Research Infrastructure Network<\/strong> (<a href=\"https:\/\/ecrin.org\/\">ECRIN<\/a>) i actualment es presta serveis a 3 assaigs cl\u00ednics independents multic\u00e8ntrics internacionals amb finan\u00e7ament de la convocat\u00f2ria H2020 i amb Suport d\u2019ECRIN.<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p><em>L\u2019Institut d&#8217;Investigaci\u00f3 Biom\u00e8dica de Bellvitge (IDIBELL) \u00e9s un centre de recerca en biomedicina creat l\u2019any 2004. Est\u00e0 participat per l&#8217;Hospital Universitari de Bellvitge i l\u2019Hospital de Viladecans de l&#8217;Institut Catal\u00e0 de la Salut, l&#8217;Institut Catal\u00e0 d&#8217;Oncologia, la Universitat de Barcelona i l\u2019Ajuntament de l\u2019Hospitalet de Llobregat.<\/em><\/p>\n<p><em>L\u2019IDIBELL \u00e9s membre del Campus d&#8217;Excel\u00b7l\u00e8ncia Internacional de la Universitat de Barcelona HUBc i forma part de la instituci\u00f3 CERCA de la Generalitat de Catalunya. L&#8217;any 2009 es va convertir en un dels cinc primers centres d\u2019investigaci\u00f3 espanyols acreditats com a institut d\u2019investigaci\u00f3 sanit\u00e0ria per l\u2019Instituto de Salud Carlos III. A m\u00e9s, forma part del programa \u201cHR Excellence in Research\u201d de la Uni\u00f3 Europea i \u00e9s membre de EATRIS i REGIC. Des de l\u2019any 2018, l\u2019IDIBELL \u00e9s un Centro Acreditado de la Fundaci\u00f3n Cient\u00edfica AECC (FCAECC).<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>L\u2019ajut concedit en la darrera convocat\u00f2ria competitiva de Plataformes de Suport a la Recerca Cl\u00ednica de l\u2019Institut de Salut Carlos III (ISCIII) gaireb\u00e9 triplica el concedit a la convocat\u00f2ria de l\u2019any 2017, essent una de les cinc unitats m\u00e9s ben dotades de les 34 que conformen la nova Plataforma de l\u2019ISCIII a tot el territori de l\u2019estat espanyol.<\/p>\n","protected":false},"author":8,"featured_media":16844,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[1],"tags":[],"class_list":["post-16843","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sin-categorizar"],"publishpress_future_action":{"enabled":false,"date":"2025-03-02 14:27:11","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category"},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/16843","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/comments?post=16843"}],"version-history":[{"count":0,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/16843\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media\/16844"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media?parent=16843"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/categories?post=16843"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/tags?post=16843"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}